Single injection of cross-linked hyaluronate in knee osteoarthritis: a 52-week double-blind randomized controlled trial

HIGHLIGHTS

  • who: Po-Yen Ko et al. from the Department of Orthopedics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan have published the research: Single Injection of Cross-Linked Hyaluronate in Knee Osteoarthritis: A 52-Week Double-Blind Randomized Controlled Trial, in the Journal: Pharmaceutics 2022, 14, 1783. of /2022/
  • what: All adverse events related to the study treatment occurred following the IAHA injection; however, they were considered of mild grade and resolved spontaneously within one week. This study examined the effectiveness and safety of HJP and Durolane for knee . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?